We are live on ! Find out more
AUTL icon

Autolus Therapeutics

63 hedge funds and large institutions have $129M invested in Autolus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

663% more capital inflows, than outflows

Capital inflows: $83.3M | Capital outflows: $10.9M

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

31% more funds holding

Funds holding: 48 → 63 (+15)

13.61% more ownership

Funds ownership: 17.27% → 30.89% (+14%)

Holders
63
Holders Change
+15
Holders Change %
+31.25%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
20
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AUTL Hedge Fund Activity: Q1 2021 in Review

63 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q1 2021, worth a combined $129M — up 15% from $113M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AUTL positions and 6 closed out — a net gain of 16 holders — while 20 added to existing stakes and 10 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $15.9M. The largest seller was Franklin Resources, exiting entirely with an estimated $5.1M sold.

  • 63 institutional investors held Autolus Therapeutics (AUTL) as of Q1 2021, up from 48 in Q4 2020.
  • Funds reported $129M of Autolus Therapeutics stock for Q1 2021, up 15% quarter-over-quarter.
  • 22 funds opened new Autolus Therapeutics positions in Q1 2021 and 6 closed out, a net change of +16 holders.
  • The largest Autolus Therapeutics buyer in Q1 2021 was Deerfield Management, an estimated $15.9M added.
  • The largest Autolus Therapeutics seller in Q1 2021 was Franklin Resources, an estimated $5.1M sold.

Based on aggregated 13F filings for Q1 2021.